Lataa...
MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1
BACKGROUND/AIMS: Nasopharyngeal carcinoma is a common head and neck cancer in South China and Southeast Asia. Radiotherapy is the standard treatment for nasopharyngeal carcinoma. Accumulating evidence showed that the expression of miR-34a was abnormal in nasopharyngeal carcinoma. Here, this study in...
Tallennettuna:
| Julkaisussa: | Technol Cancer Res Treat |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436822/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533033820940424 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|